Sofinnova Ventures »

Kenvue shares owned by Sofinnova Ventures

Quarter-by-quarter ownership of Kenvue (KVUE) shares owned by Sofinnova Ventures from 13F filings

Historical chart of Sofinnova Ventures investment in Kenvue

Tip: Access up to 7 years of quarterly data

All positions including Kenvue held by Sofinnova Ventures consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kenvue by Sofinnova Ventures

Quarter filed Position value Share count Share price at filing
2023-09-30 $36M 1.8M 20.08

More positions owned by Sofinnova Ventures

Karuna Therapeutics Ord
Natera (NTRA)
AstraZeneca Sponsored Adr (AZN)
Merck & Co (MRK)
Ascendis Pharma A/S Sponsored Adr (ASND)
Rayzebio
Dex (DXCM)
Aerovate Therapeutics (AVTE)
Intuitive Surgical (ISRG)
Vera Therapeutics Cl A (VERA)
Cytokinetics (CYTK)
Elanco Animal Health (ELAN)
IShares TR Russell 2000 Etf Put Option (IWM)
argenx SE Sponsored Adr (ARGX)
Exelixis Put Option (EXEL)

View all positions for Sofinnova Ventures

Top funds holding Kenvue

Johnson & Johnson
Vanguard Group
FMR
T. Rowe Price Associates
BlackRock
Wellington Management Company
Jpmorgan Chase & Co
Massachusetts Financial Services
Bank of America Corporation
Bank of New York Mellon
Geode Capital Management
Franklin Resources
Charles Schwab Investment Management
Pacer Advisors
Deutsche Bank Aktiengesellschaft

View all funds holding Kenvue